Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta-blockers and heart failure]

P Lechat1

  • 1Service de Pharmacologie, CHU Pitié-Salpêtrière, Paris.

Therapie
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Beta-blockade therapy offers functional benefits for heart failure patients by counteracting harmful sympathetic overstimulation. Large trials confirm this improvement, though survival benefits require further investigation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Biosimilar medicines: Regulatory issues and medico-economic impacts].

Bulletin de l'Academie nationale de medecine·2020
Same author

[Treatment of Sars-Cov2 with hydroxychloroquine is ineffective and potentially harmful].

Archives des maladies du coeur et des vaisseaux. Pratique·2020
Same author

Amoxicillin-clavulanic acid prescriptions at the Greater Paris University Hospitals (AP-HP).

Medecine et maladies infectieuses·2016
Same author

[Introduction of Health technology assessment at hospital].

Annales pharmaceutiques francaises·2016
Same author

Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancy.

The pharmacogenomics journal·2012
Same author

An excipient for suppositories, soluble in water.

Annales pharmaceutiques francaises·2010
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Context:

  • Heart failure is often associated with increased sympathetic nervous system activity.
  • The role of beta-adrenergic stimulation in heart failure pathophysiology is complex.

Purpose:

  • To evaluate the functional benefits of beta-blockade in heart failure patients.
  • To investigate the mechanisms underlying beta-blockade's effects, including receptor up-regulation.

Summary:

  • Two major trials (MDC with metoprolol, CIBIS with bisoprolol) demonstrated functional improvement in heart failure patients receiving beta-blockers.
  • Survival benefits were noted in non-ischemic heart failure patients in the CIBIS trial.
  • Further studies are needed to confirm survival benefits.

Impact:

Related Experiment Videos

  • Beta-blockade is a cornerstone therapy for heart failure, improving patient function.
  • Understanding the nuances of beta-adrenergic response is crucial for optimizing heart failure treatment.
  • These findings support the continued use and investigation of beta-blockers in managing heart failure.